{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2022-12-16", "title": "SDTM Controlled Terminology Package 52 Effective 2022-12-16", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2022-09-30/codelists/C66788", "title": "CDISC Dictionary Name Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C66788", "title": "Version-agnostic anchor resource for codelist C66788", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2022-12-16/codelists/C66788", "title": "CDISC Dictionary Name Terminology", "type": "Code List"}}, "conceptId": "C66788", "definition": "A name given to a reference source that lists words and gives their meaning. (NCI)", "extensible": "true", "name": "Dictionary Name", "preferredTerm": "CDISC Dictionary Name Terminology", "submissionValue": "DICTNAM", "synonyms": ["Dictionary Name"], "terms": [{"conceptId": "C163415", "definition": "A standard terminology developed and maintained by Clinical Data Interchange Standards Consortium (CDISC) and the National Cancer Institute Enterprise Vocabulary Services (NCI-EVS) to support CDISC models, domains and specifications for data representation in regulated research.", "preferredTerm": "Clinical Data Interchange Standards Consortium Controlled Terminology", "submissionValue": "CDISC CT", "synonyms": ["CDISC Controlled Terminology", "Clinical Data Interchange Standards Consortium Controlled Terminology"]}, {"conceptId": "C49471", "definition": "A terminology developed and used by the Food and Drug Administration (FDA) for the coding, filing and retrieving of post marketing adverse reaction reports. (NCI)", "preferredTerm": "Thesaurus of Adverse Reaction Term Coding Symbols", "submissionValue": "COSTART", "synonyms": ["Coding Symbols for a Thesaurus of Adverse Reaction Terms"]}, {"conceptId": "C49704", "definition": "A standard terminology developed and maintained by the National Cancer Institute to report adverse events occurring in cancer clinical trials. The CTCAE contains a grading scale for each adverse event term representing the severity of the event.", "preferredTerm": "Common Terminology Criteria for Adverse Events", "submissionValue": "CTCAE", "synonyms": ["Common Terminology Criteria for Adverse Events"]}, {"conceptId": "C134003", "definition": "A proprietary system developed and regulated by Dun & Bradstreet that assigns a unique nine digit numeric identifier to a single business entity location.", "preferredTerm": "Data Universal Numbering System", "submissionValue": "D-U-N-S NUMBER", "synonyms": ["Data Universal Number System", "DUNS Numbers"]}, {"conceptId": "C49474", "definition": "A system of categories to which morbid entries are assigned according to established criteria. Included is the entire range of conditions in a manageable number of categories, grouped to facilitate mortality reporting. It is produced by the World Health Organization (from ICD-10, p1). The Clinical Modifications, produced by the United States Dept. of Health and Human Services, are larger extensions used for morbidity and general epidemiological purposes, primarily in the U.S. (MSH2005_2004_10_12)", "preferredTerm": "International Classification of Diseases", "submissionValue": "ICD", "synonyms": ["International Classification of Diseases"]}, {"conceptId": "C37978", "definition": "A World Health Organization (WHO) multi-axial classification of the site, morphology, behaviour, and grading of neoplasms.", "preferredTerm": "International Classification of Diseases for Oncology", "submissionValue": "ICD-O", "synonyms": ["International Classification of Diseases for Oncology"]}, {"conceptId": "C49476", "definition": "Published by The Regenstrief Institute, the Logical Observation Identifiers Names and Codes covers clinical and clinical laboratory terminology. (NCI)", "preferredTerm": "Logical Observation Identifiers Names and Codes", "submissionValue": "LOINC", "synonyms": ["Logical Observation Identifiers Names and Codes"]}, {"conceptId": "C163416", "definition": "A standard terminology developed and maintained by the Veterans Health Administration (VHA) that includes terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of medications. MED-RT incorporates terminology from RxNORM, MeSH, and SNOMED CT.", "preferredTerm": "Medication Reference Terminology", "submissionValue": "MED-RT", "synonyms": ["Medication Reference Terminology", "NDF-RT"]}, {"conceptId": "C43820", "definition": "MedDRA is an international medical terminology designed to support the classification, retrieval, presentation, and communication of medical information throughout the medical product regulatory cycle. MedDRA was developed under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). The MedDRA Maintenance and Support Services Organization (MSSO) holds a contract with the International Federation of Pharmaceutical Manufacturers Associations (IFPMA) to maintain and support the implementation of the terminology. (NCI)", "preferredTerm": "MedDRA", "submissionValue": "MedDRA", "synonyms": ["Medical Dictionary for Regulatory Activities"]}, {"conceptId": "C53489", "definition": "A multiaxial, hierarchical classification system for diseases in man developed by the College of American Pathologists. (NCI)", "preferredTerm": "Systematized Nomenclature of Medicine", "submissionValue": "SNOMED", "synonyms": ["Systematized Nomenclature of Medicine"]}, {"conceptId": "C163417", "definition": "A standard terminology developed and maintained by the Department of Veterans Affairs/Veterans Health Administration designated federal collaborative Structured Product Labeling Interagency Expert Panel (SPLIEP). It contains terminology to support the mechanism of action, physiologic effect, and asserted pharmacologic classification relationships of drug ingredients and food allergens.", "preferredTerm": "Substance Registration System-Unique Ingredient Identifier", "submissionValue": "UNII", "synonyms": ["SRS-UNII", "Substance Registration System-Unique Ingredient Identifier"]}, {"conceptId": "C154331", "definition": "A World Health Organization (WHO) classification system, developed and maintained by the WHO Collaborating Centre for Drug Statistics Methodology, for medicinal substances where active substances are divided into different groups according to the organ or system on which they act and their therapeutic, pharmacological, and chemical properties.", "preferredTerm": "Anatomical Therapeutic Chemical Classification System", "submissionValue": "WHO ATC CLASSIFICATION SYSTEM", "synonyms": ["Anatomical Therapeutic Chemical Classification System"]}, {"conceptId": "C49468", "definition": "A terminology implemented by the World Health Organization to describe adverse reactions to a prescribed medication or treatment regimen. (NCI)", "preferredTerm": "World Health Organization Adverse Reaction Terminology", "submissionValue": "WHOART", "synonyms": ["World Health Organization Adverse Reaction Terms"]}, {"conceptId": "C49475", "definition": "A reference source of drugs and drug associated information maintained by the World Health Organization. (NCI)", "preferredTerm": "World Health Organization Drug Dictionary", "submissionValue": "WHODD", "synonyms": ["WHODrug Global", "World Health Organization Drug Dictionary"]}]}